Related Experiment Video
Updated: Apr 12, 2026
Generation of Human Monocyte-derived Dendritic Cells from Whole Blood
Published on: December 24, 2016
In vitro generation of functional dendritic cells differentiated from CD34 negative cells isolated from human
Yo Seph Park1,2, Changsik Shin3, Han Sung Hwang4
1Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, 143-701, Korea.
Insights
Human umbilical cord blood contains hematopoietic stem cells (HSCs) that can generate dendritic cells (DCs). Researchers found that both CD34-positive and CD34-negative cells from cord blood can effectively differentiate into DCs, suggesting broader potential for DC generation.
Area of Science:
- Immunology
- Cell Biology
- Hematology
Background:
- Dendritic cells (DCs) are potent antigen-presenting cells vital for initiating immune responses.
- Increasing therapeutic applications of DCs necessitate large-scale production for transplantation.
- Human umbilical cord blood (UCB) harbors hematopoietic stem cells (HSCs) capable of differentiating into DCs.
Purpose of the Study:
- To investigate the potential of CD34-positive (CD34+) and CD34-negative (CD34-) cells isolated from human UCB to differentiate into DCs.
- To compare the DC differentiation capacity of CD34+ and CD34- cell populations.
Main Methods:
- Isolation of CD34+ and CD34- cells from human UCB using a two-step method and magnetic bead sorting.
- Assessment of DC differentiation potential through cellular property analysis.
- Functional evaluation using migration and T cell proliferation assays.
Main Results:
- No significant differences were observed in the ability of CD34+ and CD34- cells to generate DCs.
- Both isolated cell populations demonstrated comparable DC differentiation potential.
- Functional assays confirmed similar capabilities in migration and T cell stimulation between DCs derived from both populations.
Conclusions:
- The CD34 marker is not essential for identifying UCB-derived cells with robust DC differentiation capacity.
- Both CD34+ and CD34- fractions of UCB possess significant potential for generating functional DCs.
- These findings broaden the scope for utilizing UCB as a source for clinical-grade dendritic cell production.
Abstract:
Dendritic cells (DCs) are the most potent antigen-presenting cells that play a crucial role in the initiation of an immune response. As DC-based therapeutic applications is increasing, large-scale DC production is required for transplantation. Human umbilical cord blood (UCB) has been shown to contain a rare and precious population of hematopoietic stem cells (HSCs), which can give rise to DCs. The CD34 antigen has been widely used as a cell surface marker to identify HSCs. In this study, we used CD34 antibody to isolate CD34(+) and CD34(-) cells and compared the ability to differentiate into DCs. We used a two-step method combined with the magnetic bead sorting system to isolate CD34(+) and CD34(-) cells from human UCB. Analysis of cellular properties and functionality using a migration assay and T cell proliferation assay revealed no significant differences between CD34(+) cells and CD34(-) cells in their ability to generate DCs.
